Yayınlar & Eserler

Yayın Ağı
Makaleler 8
Tümü (8)
SCI-E, SSCI, AHCI (5)
SCI-E, SSCI, AHCI, ESCI (5)
Scopus (6)
TRDizin (1)
Diğer Yayınlar (1)

1. Cellular parabioisis as a senotherapeutic approach.

Sencan S., Onaran I.
Advances in pharmacology (San Diego, Calif.) , cilt.104, ss.227-258, 2025 (Scopus) identifier

2. A novel anticancer candidate, coumarin-3-carboxamide derivative inhibits cell proliferation and migration in MDA-MB-231 cell line

ŞENCAN S., ÇELİK ONAR H.
Journal of Receptors and Signal Transduction , cilt.45, sa.4, ss.230-236, 2025 (SCI-Expanded, Scopus) identifier identifier

3. SCN5A promotes the growth and lung metastasis of triple-negative breast cancer through EF2-kinase signaling

Erdogan M. A., Yuca E., Ashour A., Gurbuz N., ŞENCAN S., Ozpolat B.
Life Sciences , cilt.313, 2023 (SCI-Expanded, Scopus) identifier identifier

4. The Importance of Autophagy Mechanism as a Novel Therapeutic Target in SARS-CoV-2

ŞENCAN S.
Aksaray Üniversitesi Tıp Bilimleri Dergisi , cilt.2, sa.3, ss.30-33, 2021 (Hakemli Dergi)

5. UV radiation resistance-associated gene (UVRAG) promotes cell proliferation, migration, invasion by regulating cyclin-dependent kinases (CDK) and integrin-β/Src signaling in breast cancer cells

ŞENCAN S., Tanriover M., Ulasli M., Karakas D., Ozpolat B.
Molecular and Cellular Biochemistry , cilt.476, sa.5, ss.2075-2084, 2021 (SCI-Expanded, Scopus) identifier identifier

6. Gene expressions of TRP channels in glioblastoma multiforme and relation with survival

Alptekin M., Eroglu S., Tutar E., ŞENCAN S., Geyik M., Ulasli M., et al.
Tumor Biology , cilt.36, sa.12, ss.9209-9213, 2015 (SCI-Expanded, Scopus) identifier identifier

7. Toxic-dose warfarin-induced apoptosis and its enhancement by gamma ionizing radiation in leukemia K562 and HL-60 cells is not mediated by induction of oxidative stress

ONARAN İ., ŞENCAN S., Demirtaş H., Aydemir B., ULUTİN A. N. T., OKUTAN M.
Naunyn-Schmiedeberg's Archives of Pharmacology , cilt.378, sa.5, ss.471-481, 2008 (SCI-Expanded, Scopus) identifier identifier

8. Warfarin’in Sitotoksik Etkisinin K562 Lösemik Hücre Soyunda Çalışılması

ŞENCAN S., ONARAN İ., DEMİRTAŞ H.
Sağlık Bilimleri Dergisi , 2007 (TRDizin)
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 3

1. Expression levels of LC3 and Transmembrane Protein 74 (TMEM74) in breast cancer

ŞENCAN S., KALENDER M. E., ULAŞLI M., CAMCI C., ARSLAN A.
13th Asia-Pasific Oncologists Annual Meeting, Kuala-Lumpur, Malezya, 17 - 19 Ekim 2016, (Özet Bildiri)

2. Expression of ATG4A, ATG4B, ATGC, ATG4D in breast cancer and relation with prognostic factors

ŞENCAN S., KALENDER M. E., ULAŞLI M., ÖZTUZCU S., BORAZAN E., KIRKBEŞ S., et al.
37th International Association of Cancer Registries (IACR), Mumbai, Hindistan, 8 - 10 Ekim 2015, (Özet Bildiri)

3. May Warfarin Have A Cytotoxic Effect In Relation To An Prooxidant Action With A Direct Effect On Cancer Cells? A Study In Leukaemia K562

ŞENCAN S., ONARAN İ., KERİMOVA A., DEMİRTAŞ H., ULUTİN A. N. T.
19th International Congresson Thrombosis, Tel-Aviv-Yafo, İsrail, 14 Mayıs 2006, (Özet Bildiri)
Kitaplar 2

1. Kanserde Yeni Terapötik Hedefler Olarak Semaforinler

ŞENCAN S.
Kanser Olgularına Multidisipliner Yaklaşım, Alper KARAGÖZ, Editör, Gece Kitaplığı, Ankara, ss.359-367, 2023

2. MicroRNAs Modulating Autophagy Pathway

ŞENCAN S.
Recent Advances in Molecular Biology and Biochemistry, Mesut IŞIK, Editör, Biyomit Publisher, İstanbul, ss.252-256, 2023